← Back to Search

Behavioural Intervention

Diabetes Prevention Program for Prediabetes (BRIDGE Trial)

N/A
Recruiting
Led By Jeannette Beasley, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of pre-diabetes (A1c between 5.7-6.4%, fasting glucose between 100-125 mg/dL, or oral glucose tolerance test between 140-199 mg/dL within past 12 months)
Able to travel to NYU Langone for in-person evaluations
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline visit, 6 months visit, 12 month visit
Awards & highlights

BRIDGE Trial Summary

This trial is testing whether a diabetes prevention program tailored for older adults and delivered via Telehealth is more effective and easier to implement than the same program delivered in person.

Who is the study for?
This trial is for English or Spanish-speaking men and women aged 65 and older with prediabetes, under NYU Langone Health's care. Participants must have a BMI of 30 or more, be able to travel for in-person evaluations, have access to a phone, and not have taken part in the Diabetes Prevention Program before.Check my eligibility
What is being tested?
The study compares two versions of the Diabetes Prevention Program (DPP): one delivered in person and another tailored for older adults via telehealth. It aims to see which method is more effective at preventing diabetes among seniors.See study design
What are the potential side effects?
Since this trial involves lifestyle interventions like diet changes and physical activity rather than medication, side effects may include muscle soreness from exercise or dietary adjustments discomfort but are generally minimal.

BRIDGE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with pre-diabetes based on recent tests.
Select...
I can travel to NYU Langone for check-ups.

BRIDGE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline visit, 6 months visit, 12 month visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline visit, 6 months visit, 12 month visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in HbA1c in participants in DPP-TOAT is similar to those in In-Person DPP
Changes in weight in participants in DPP-TOAT is similar to those in In-Person DPP
Secondary outcome measures
Adherence to the DPP-TOAT is greater than the in-person DPP

BRIDGE Trial Design

2Treatment groups
Active Control
Group I: In-person Diabetes Prevention Program (DPP)Active Control1 Intervention
Participants randomized to the in-person DPP intervention for 12 months
Group II: DPP program Tailored for Older Adults and delivered via Telehealth (DPP-TOAT arm)Active Control1 Intervention
Participants randomized to the DPP program Tailored for Older Adults and delivered via Telehealth (DPP-TOAT arm) intervention for 12 months.

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,358 Previous Clinical Trials
4,315,011 Total Patients Enrolled
NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,496 Total Patients Enrolled
Jeannette Beasley, MDPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
16 Total Patients Enrolled

Media Library

DPP (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05166785 — N/A
Prediabetes Research Study Groups: In-person Diabetes Prevention Program (DPP), DPP program Tailored for Older Adults and delivered via Telehealth (DPP-TOAT arm)
Prediabetes Clinical Trial 2023: DPP Highlights & Side Effects. Trial Name: NCT05166785 — N/A
DPP (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05166785 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to enroll in this clinical research experiment currently?

"Per the information on clinicaltrials.gov, this trial is in full recruitment mode. It was first made available to potential candidates on October 5th 2022 and its most recent update was issued one day later."

Answered by AI

What is the upper limit for recruitment into this experiment?

"Affirmative. Per clinicaltrials.gov, this medical study is actively recruiting patients since its initial posting on the 5th of October 2022 and updated most recently on the 6th of October. The trial seeks to enrol 230 participants from a single location."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
NYU Langone Health
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
BRInging the Diabetes Prevention Program to GEriatric Populations
2022. "BRInging the Diabetes Prevention Program to GEriatric Populations". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05166785.
All > Prediabetes
~131 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top